Recently, Alioth Biotech (Shanghai) Co., Ltd. has been certified as a National High-Tech Enterprise, on the strength of its sustained R&D and innovation capability, solid technical foundation, and disciplined management.
The National High-Tech Enterprise title is one of the most hard-won honors for a Chinese tech company. The bar is high: certification weighs core independent IP, R&D spend, commercialization of results, and growth potential — across the board. Earning it puts a company's technical and innovation capability in the national top tier.
For Alioth, the certification is the state's nod to our in-house R&D and technical innovation — and a mark that we've stepped up on both technology development and turning research into shipped products.
Going forward, we'll use this certification as a springboard: hold the line on innovation, go deeper on core technology, keep widening the product pipeline, and push harder on breakthroughs in membrane materials — so the moat around our core tech keeps growing. We'll keep working toward home-grown command of the upstream, high-barrier technologies in biopharma processing, and toward replacing imported products with our own — so the biopharma supply chain is more secure, and the industry as a whole moves forward.